Team

Professor Brian Austen Email	Molecular organisation and cellular processing of neurotoxic amyloids, and their role in Alzheimer's disease and familial British dementia. Quantitation of amyloid species by antibody-capture mass spectrometry. The role of intracellular cholesterol in amyloidogenesis. Chemical synthesis of inhibitors of amyloid oligomerisation and toxicity. Synthesis of secretase inhibitors.
Gill Gibson Email	A PhD from Lancaster University; working on the generation of a transgenic model of BRI-related dementias supported by a Wellcome Trust grant
Mr. Victor Lelyveld Email	Victor has shown that the peptide ADan released into the brains of the patients with Danish Dementia forms soluble oligomers which are toxic. He has built a molecular model of the oligomer formation, which is in use for the design of new therapeutic.
Anna Isbister Email	An exchange student from Victoria University, Canada; is working on the mechanisms of neurodegeneration of BRI peptides a cause of familial dementias
William Tucker Email	Invetsigating the protection of chaperonins in amyloid-induced neuronal death
Ms. Jocelyn Frimpong-Manso Email
Mr. Chibuu Liu Email
Mrs. Georgina Christodoulou Email	Health care and bed occupancy modelling; information processing and analysis; and dissemination.
Ms. Cressida Darwin Email	Transcultural aspects of dementia care; ethnic minority elderly in primary care; quality of life; the contribution of philosophy and spirituality to dementia care and elderly care in general.
Dr. Robert Lawrence Email	Psychopathology, early diagnosis, treatment and management of neurodegenerative disease; presenile dementia; ethical aspects of dementia care (awareness, insight, capacity, self-determination ); the contribution of philosophy and spirituality to dementia care and elderly care in general.

These pages were created and are maintained by Georgina Christodoulou.
Last update 20.05.2003 .